GSK plc
GSK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 1,048 institutions reported holding it in 13F filings for Q2 2026, worth $18.2B in total; no superinvestor holds it.
Other share classesGLAXF
Q4 2021 vs. Q3 2021
How the institutions holding GSK plc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 796 | 14 | 921 | +139 |
| Shares | 323.6M | 185.7K | 327.8M | +4.45M (+1.4%) |
| Value | $12.4B | $7.03M | $14.5B | +$2.09B (+16.9%) |
14 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (192)
Institutions that held GSK plc at the end of Q4 2021 but not at the end of Q3 2021.
Showing the largest 100 of 192 by value.
Sold out (53)
Institutions that held GSK plc at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (14)
Institutions that held GSK plc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3.82M |
| Elevated Capital Advisors, LLC | 20,017 | $765.0K |
| HighPoint Advisor Group LLC | 15,255 | $583.0K |
| Ameritas Investment Company, LLC | 13,159 | $503.0K |
| Weather Gauge Advisory, LLC | 12,148 | $464.0K |
| Eudaimonia Partners, LLC | 7,615 | $291.0K |
| Mid Atlantic Financial Management Inc | 6,706 | $256.0K |
| Farr Miller & Washington LLC | 5,598 | $214.0K |
| Sonora Investment Management, LLC | 1,472 | $56.0K |
| Berman Capital Advisors, LLC | 625 | $23.0K |
| Wealth Quarterback LLC | 2,482 | $23.0K |
| BBVA USA | 367 | $14.0K |
| Security National Trust Co | 145 | $6.00K |
| Heritage Wealth Management, LLC | 147 | $6.00K |